Commentators are making a big fuss over the U.S. dollar’s sharp rise, as well as efforts to dethrone the greenback. We debunk a few myths. Read More
Analyst Articles
The U.S. Dept. of Veterans Affairs has revived a 60-year-old effort to study psychedelics as a means of mental health therapy for vets. Read More
Economic growth, the jobs market, inflation, and monetary policy are simultaneously going through a post-COVID period of normalization. Read More
The BLS on June 7 reported a hotter-than-expected jobs market for May, which is renewing inflation fears. Here are specific steps to take now. Read More
We all know that the “green rush” is an enormous investment opportunity. But here are yardsticks to ensure you pick intrinsically sound cannabis stocks. Read More
Nvidia has been leading the tech stock surge. However, former laggards in other sectors are catching up, creating a more diversified market. Read More
Corporate icons can seem invulnerable. But as with the Titanic, undetected flaws can sink even famous names. Here are 10 red flags of lurking trouble. Read More
Most Americans are down on the economy and the stock market, despite economic growth and the equity rally. Here’s a look at objective reality. Read More
The U.S. economy is decelerating but that’s actually a good thing, because it relieves inflationary pressures. Read More
This week, Canada achieved a milestone in medicinal psychedelics as it granted authorization to a fledgling company to export these compounds. Read More